Abstract
Dacarbazine (DTIC) is an antitumor agent that has limited clinical applications due to its insolubility, instability and toxicity to normal cells. One possibility to achieve controlled release is PVA-based NPs. This work presents electrospun NPs that combines PVA and DTIC. The results showed that DTIC NPs had mean particle sizes of 458.2 ± 113.6 nm, suggested the presence of DTIC in an amorphous state and showed a burst in vitro drug release followed by constant release. The cytotoxicity evaluation showed that DTIC NPs were effective against glioblastoma cells. This study indicates that the formulated NPs improved DTIC solubility and efficacy.
Graphical Abstract
![](/cms/asset/3525ad01-28be-42b7-8150-f51a3276117a/gpom_a_1605606_uf0001_c.jpg)
Acknowledgements
We thank Dr. Wynette Redington (Bernal Institute, University of Limerick) for assistance with XRD analysis.
Disclosure statement
The authors declare that there are no conflict of interest.
Statement of authors' contributions to manuscript
L.S, B.S.C and Z.C. conducted the experiments; L.S., D.J.M. and M.N. wrote the paper. All authors read and approved the final manuscript.